Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Akebia Therapeutics (AKBA) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/05/21
Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company MilestonesPRNewsWire • 08/05/21
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akebia Therapeutics, Inc. and Encourages Investors who Formerly Held Shares of Keryx Biopharmaceuticals (KERX) to Contact the FirmBusiness Wire • 07/27/21
SHAREHOLDER ALERT: Robbins LLP Announces that Akebia Therapeutics, Inc. (AKBA) is Being Sued for Misleading Keryx Biopharmaceuticals, Inc. (KERX) Shareholders Ahead of MergerBusiness Wire • 07/26/21
Akebia Therapeutics to Report Second Quarter 2021 Financial Results and Discuss Recent Business HighlightsPRNewsWire • 07/26/21
Akebia Therapeutics Stock Jumps as FDA Accepts Vadadustat US Application in CKD-Related AnemiaBenzinga • 06/01/21
Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on DialysisPRNewsWire • 06/01/21
Implied Volatility Surging for Akebia Therapeutics (AKBA) Stock OptionsZacks Investment Research • 05/25/21
Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/10/21
Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company MilestonesPRNewsWire • 05/10/21
New England Journal of Medicine Publishes Results of Global Phase 3 Clinical Program of Vadadustat for the Treatment of Anemia Due to Chronic Kidney DiseasePRNewsWire • 04/28/21
Akebia Therapeutics to Report First Quarter 2021 Financial Results and Discuss Recent Business HighlightsPRNewsWire • 04/28/21
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Akebia Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 04/26/21
Akebia Therapeutics to Present at 20th Annual Needham Virtual Healthcare ConferencePRNewsWire • 04/12/21